HomeNDC LookupIngredients › Ethacrynate Sodium
📦 NDC / package directory — not a drug information page

Ethacrynate Sodium NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Ethacrynate Sodium products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

4
Package NDCs
5
Products
5
Active listings
0
Discontinued
4
Labelers
2
Strengths
4
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
ETHACRYNATE SODIUM 50 mg/50mL 4
ETHACRYNATE SODIUM 1 g/g 1
By dosage form
INJECTION, POWDER, FOR SOLUTION 2
INJECTION, POWDER, LYOPHILIZED, FO... 1
POWDER 1
POWDER, FOR SOLUTION 1
Top labelers
Par Health USA, LLC 2
Enaltec Labs Private Limited 1
Leading Pharma, LLC 1
Patheon Manufacturing Services LLC 1

Browse records — 5 products

Drug / product Billing NDC NADAC / unit Status
ETHACRYNATE SODIUM 50 mg/50mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Leading · NDC 69315-0701-50 · 1 VIAL, SINGLE-DOSE in 1 CARTON (69315-701-50) / 50 mL in 1 VIAL, SINGLE-DOSE 69315-0701-50 On market View →
ETHACRYNATE SODIUM 50 mg/50mL INJECTION, POWDER, FOR SOLUTION Par · NDC 42023-0157-01 · 1 VIAL in 1 CARTON (42023-157-01) / 50 mL in 1 VIAL 42023-0157-01 On market View →
Ethacrynate Sodium 1 g/g POWDER Enaltec · NDC 42413-0062-01 · 100 g in 1 BAG (42413-0062-1) 42413-0062-01 On market View →
ethacrynate sodium 50 mg/50mL POWDER, FOR SOLUTION Patheon · NDC 63552-0145-00 · 48 VIAL in 1 CASE (63552-145-00) / 50 mL in 1 VIAL 63552-0145-00 On market View →
ETHACRYNATE SODIUM 50 mg/50mL INJECTION, POWDER, FOR SOLUTION Par · NDC 42023-0157-01 · 1 VIAL in 1 CARTON (42023-157-01) / 50 mL in 1 VIAL 42023-0157-01 On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.